Home > Insider Trading > Filing (0001144204-15-041417)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1453001	Vaccinogen Inc	VGEN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1585414	Jr G Michael Hanna	39572 North Cotton Patch Hills Suite 406 Bethany Beach DE 19930		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2015-02-09	3,000	$3.50	282,487	No	4	S	Direct
Common Stock	Disposition	2015-02-10	71	$3.50	282,416	No	4	S	Direct
Common Stock	Disposition	2015-02-11	1,929	$3.50	280,487	No	4	S	Direct
Common Stock	Disposition	2015-02-19	3,400	$3.58	277,087	No	4	S	Direct
Common Stock	Disposition	2015-02-26	12,744	$3.62	264,343	No	4	S	Direct
Common Stock	Disposition	2015-02-27	2,856	$3.70	261,487	No	4	S	Direct
Common Stock	Disposition	2015-03-03	400	$3.70	261,087	No	4	S	Direct
Common Stock	Disposition	2015-03-20	4,000	$3.75	257,087	No	4	S	Direct
Common Stock	Disposition	2015-03-23	5,000	$3.65	252,087	No	4	S	Direct
Common Stock	Disposition	2015-03-27	3,000	$3.71	249,087	No	4	S	Direct
Common Stock	Disposition	2015-03-30	72	$3.75	249,015	No	4	S	Direct
Common Stock	Disposition	2015-03-31	13,928	$3.70	235,087	No	4	S	Direct
Common Stock	Disposition	2015-04-09	400	$4.00	234,687	No	4	S	Direct
Common Stock	Disposition	2015-04-10	1,000	$4.00	233,687	No	4	S	Direct
Common Stock	Disposition	2015-04-13	2,600	$4.00	231,087	No	4	S	Direct
Common Stock	Disposition	2015-04-14	100	$4.00	230,987	No	4	S	Direct
Common Stock	Disposition	2015-04-17	100	$4.00	230,887	No	4	S	Direct
Common Stock	Disposition	2015-04-21	4,900	$4.00	225,987	No	4	S	Direct
Common Stock	Disposition	2015-04-23	400	$4.00	225,587	No	4	S	Direct
Common Stock	Disposition	2015-04-30	1,000	$3.61	224,587	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,423,839	Indirect	By Hanna Enterprises, LLC

Footnotes

The number of shares reported in Column 5 throughout this filing reflects the number of shares beneficially owned as of the date of this filing and takes into account transactions reported on Form 4 since the date of the transactions reported herein.
These shares are owned directly by Michael G. Hanna, Jr.
The price reported in Column 4 is the weighted average price. These shares were sold in two transactions at prices of $3.55 and $3.60.
The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $3.58 to $3.70, inclusive. The reporting person undertakes to provide to Vaccinogen, Inc., any security holder of Vaccinogen, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5) to this Form 4.
The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $3.55 to $3.80, inclusive.
These shares are owned directly by Hanna Enterprises, LLC, and indirectly by Michael G. Hanna, Jr. as a member and manager of Hanna Enterprises, LLC.